BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22578373)

  • 1. AABB contributions to plasma safety.
    Triulzi DJ
    Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
    [No Abstract]   [Full Text] [Related]  

  • 2. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
    Gallagher LM; Ganz PR; Yang H; Kessler DA; O'Brien SF; Custer BS; Busch MP; Dodd RY; Stramer SL; Walderhaug MO; Forshee RA; Williams AE; Epstein JS; Anderson SA
    Transfusion; 2013 Feb; 53(2):455-63. PubMed ID: 22845334
    [No Abstract]   [Full Text] [Related]  

  • 4. How we manage AB plasma inventory in the blood center and transfusion service.
    Yazer M; Eder AF; Land KJ
    Transfusion; 2013 Aug; 53(8):1627-33. PubMed ID: 23614505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 7. [Time to introduce audit of transfusion treatment. Local transfusion committees should be established in Sweden].
    Schött U; Norda R; Ostlund I; Wikman A
    Lakartidningen; 2010 Dec 15-21; 107(50):3216-20. PubMed ID: 21294336
    [No Abstract]   [Full Text] [Related]  

  • 8. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated circulatory overload risk mitigation: survey on hospital policies for compliance with AABB Standard 5.9.17.
    Yazer MH; Dunbar NM; Thomas J; Nunes E; Murphy MF;
    Transfusion; 2019 Sep; 59(9):2833-2839. PubMed ID: 31393616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of methods used to detect bacterial contamination of platelet products in the United States in 2011.
    Brecher ME; Jacobs MR; Katz LM; Jacobson J; Riposo J; Carr-Greer A; Kleinman S;
    Transfusion; 2013 Apr; 53(4):911-8. PubMed ID: 23461271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we ... integrate transfusion medicine and tissue dispensing programs in an academic medical center: response to a changing regulatory environment.
    Maitta RW; Avery L; Champion M; Vaughn D; Baillargeon C; Lederer J; Snyder EL
    Transfusion; 2012 Jun; 52(6):1172-81. PubMed ID: 21981598
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
    Holland LL; Brooks JP
    Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal transfusions.
    New HV; Stanworth SJ; Engelfriet CP; Reesink HW; McQuilten ZK; Savoia HF; Wood EM; Olyntho S; Trigo F; Wendel S; Lin Y; Hume H; Petäjä J; Krusius T; Villa S; Ghirardello S; von Lindern J; Brand A; Hendrickson JE; Josephson CD; Strauss RG; Luban NL; Paul W
    Vox Sang; 2009 Jan; 96(1):62-85. PubMed ID: 19121200
    [No Abstract]   [Full Text] [Related]  

  • 14. International views on universal leucodepletion: the perspective in The Netherlands.
    de Wit HC
    Transfus Sci; 1998 Dec; 19(4):353-4. PubMed ID: 10351153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Saving patient blood: a new rule of life? Focus on pre-operative anemia].
    Peoc'h K
    Ann Biol Clin (Paris); 2019 Feb; 77(1):7-9. PubMed ID: 30799302
    [No Abstract]   [Full Text] [Related]  

  • 16. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood component recalls and market withdrawals: frequency, reasons, and management in the United States.
    Ramsey G
    Transfus Med Rev; 2013 Apr; 27(2):82-90. PubMed ID: 23375736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of transfusion related acute lung injuries after donor plasma transfusion in obstetrics].
    Appalup MV; Rogachevskiĭ OV; Fedorova TA; Sokologorskiĭ SV
    Anesteziol Reanimatol; 2010; (6):51-5. PubMed ID: 21404450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-based decision-making for blood safety: preliminary report of a consensus conference.
    Stein J; Besley J; Brook C; Hamill M; Klein E; Krewski D; Murphy G; Richardson M; Sirna J; Skinner M; Steiner R; van Aken P; Devine D
    Vox Sang; 2011 Nov; 101(4):277-81. PubMed ID: 21781125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.